U.S. costs saved through generics by therapy 2004-2013

This statistic displays the distribution of cost savings in the United States associated with using generic pharmaceuticals within the period 2004-2013, by therapeutic area. During this period, one percent of cost savings due to generic pharmaceuticals were within the blood disorder therapy area. Over the last decade, 1.46 trillion U.S. dollars were saved through the use of generic pharmaceuticals in the United States.

Distribution of cost savings through generics in the United States in the period 2004-2013, by therapeutic area

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
33% Discount until September 30th
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

October 2014

Region

United States

Survey time period

2004 to 2013

Open this statistic in...
Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract; Prices do not include sales tax.

Statistics on "Generics and biosimilars"

Further Content: You might find this interesting as well

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.